
Methylcobalamin (1500mcg) + Nortriptyline (10mg) + Pregabalin (75mg)
Active composition
+2 more active ingredients
Methylcobalamin acts as a cofactor in the synthesis of methionine from homocysteine, promoting nerve health and red blood cell formation.
Nortriptyline inhibits the reuptake of norepinephrine and serotonin, increasing their levels in the synaptic cleft and enhancing mood.
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Medical applications
Nurowin-Plus Tablet SR is a sustained-release formulation combining Pregabalin 75mg, Nortriptyline 10mg, and Methylcobalamin 1500mcg, designed for the management of neuropathic pain and associated neurological disorders. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, modulates calcium channels to inhibit excitatory neurotransmitter release, thereby reducing neuropathic pain and seizures. Nortriptyline, a tricyclic antidepressant, enhances noradrenergic and serotonergic neurotransmission, providing analgesic and mood-stabilizing effects beneficial in chronic pain syndromes. Methylcobalamin, an active form of vitamin B12, supports nerve regeneration and repair by promoting myelin sheath synthesis and neuronal function. The sustained-release mechanism ensures prolonged therapeutic plasma concentrations, improving patient compliance and minimizing dosing frequency. Nurowin-Plus is indicated for diabetic neuropathy, post-herpetic neuralgia, peripheral neuropathies, and other neuropathic pain conditions. It may also aid in the treatment of depression and anxiety associated with chronic pain. Caution is advised in patients with renal impairment, cardiac conditions, or those on concomitant CNS depressants. Common adverse effects include dizziness, somnolence, dry mouth, and gastrointestinal disturbances. Nurowin-Plus should be prescribed under medical supervision with appropriate dose adjustments based on clinical response and tolerability.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nurowin-Plus Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Nurowin-Plus Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Nurowin-Plus Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Nurowin-Plus Tablet SR may be needed. Please consult your doctor.
Exercise Caution
Nurowin-Plus Tablet SR may cause side effects which could affect your ability to drive. As Nurowin-Plus Tablet SR may affect your alertness which may affect your ability to drive.
Consult Doctor
Nurowin-Plus Tablet SR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Nurowin-Plus Tablet SR may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Nurowin-Plus Tablet SR

Pregabalin (75mg) + Nortriptyline (10mg) + Methylcobalamin (1500mcg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Methylcobalamin acts as a cofactor in the synthesis of methionine from homocysteine, promoting nerve health and red blood cell formation.
Nortriptyline inhibits the reuptake of norepinephrine and serotonin, increasing their levels in the synaptic cleft and enhancing mood.
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Medical applications
Nurowin-Plus Tablet SR is a sustained-release formulation combining Pregabalin 75mg, Nortriptyline 10mg, and Methylcobalamin 1500mcg, designed for the management of neuropathic pain and associated neurological disorders. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, modulates calcium channels to inhibit excitatory neurotransmitter release, thereby reducing neuropathic pain and seizures. Nortriptyline, a tricyclic antidepressant, enhances noradrenergic and serotonergic neurotransmission, providing analgesic and mood-stabilizing effects beneficial in chronic pain syndromes. Methylcobalamin, an active form of vitamin B12, supports nerve regeneration and repair by promoting myelin sheath synthesis and neuronal function. The sustained-release mechanism ensures prolonged therapeutic plasma concentrations, improving patient compliance and minimizing dosing frequency. Nurowin-Plus is indicated for diabetic neuropathy, post-herpetic neuralgia, peripheral neuropathies, and other neuropathic pain conditions. It may also aid in the treatment of depression and anxiety associated with chronic pain. Caution is advised in patients with renal impairment, cardiac conditions, or those on concomitant CNS depressants. Common adverse effects include dizziness, somnolence, dry mouth, and gastrointestinal disturbances. Nurowin-Plus should be prescribed under medical supervision with appropriate dose adjustments based on clinical response and tolerability.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nurowin-Plus Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Nurowin-Plus Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Nurowin-Plus Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Nurowin-Plus Tablet SR may be needed. Please consult your doctor.
Exercise Caution
Nurowin-Plus Tablet SR may cause side effects which could affect your ability to drive. As Nurowin-Plus Tablet SR may affect your alertness which may affect your ability to drive.
Consult Doctor
Nurowin-Plus Tablet SR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Nurowin-Plus Tablet SR may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Nurowin-Plus Tablet SR















